Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$192,950
in 1 filing, $193K under 10b5-1 plans

Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Meek David D. −$193K Director sold 23% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-13 Soteropoulos Paula Director Grant or award · Stock Option (Right to Buy) +17,060 17,060
2023-06-13 POST LEONARD E Director Grant or award +8,700 20,512
2023-06-13 POST LEONARD E Director Grant or award · Stock Option (Right to Buy) +17,060 17,060
2023-06-13 Meek David D. Director Grant or award +8,700 24,771
2023-06-13 Meek David D. Director Grant or award · Stock Option (Right to Buy) +17,060 17,060
2023-06-13 Kaye Jack Director Grant or award +8,700 36,399
2023-06-13 Kaye Jack Director Grant or award · Stock Option (Right to Buy) +17,060 17,060
2023-06-13 Gut Robert Director Grant or award +8,700 50,897
2023-06-13 Gut Robert Director Grant or award · Stock Option (Right to Buy) +17,060 17,060
2023-06-13 Balachandran Madhavan Director Grant or award +8,700 28,273
2023-06-13 Balachandran Madhavan Director Grant or award · Stock Option (Right to Buy) +17,060 17,060

Page 13 of 13 · 251 trades